Belgian pharma warns EU drug reform risks entrenching decline

EURACTIV - Belgium's biopharmaceutical industry has delivered a muted verdict on the EU's landmark overhaul of pharmaceutical legislation, warning that the deal fails to reverse Europe's slide in global competitiveness and calling it "a missed opportunity to reverse the declining trend in Europe." Read more

[Getty Images: Traimak_Ivan]